860-861 / 1173
ESTRO
Potential added-value of PET for TV selection
Grégoire, 2004
Comparison between CT and FDG-PET
for nodal staging.
Site
Sensitivity
Specif icity
CT
FDG-PET
CT
FDG-PET
Head and neck cancer
36-86%
50-96%
56-100% 88-100%
NSC lung cancer
45%
80-90%
85%
85-100%
Cervix carcinoma
57-73%
1
75-91%
83-100%
1
92-100%
Esophageal cancer
11-87%
30-78%
28-99%
86-98%
1
CT or MRI
?